Other Stories

S. Korean regulator to consider Remdesivir to treat COVID-19 Updated: 2020-05-29 17:02:14 KST

As new COVID-19 outbreaks flare with the easing of high intensity social distancing restrictions, South Korea plans to request imports of Gilead's anti-viral drug remdesivir to treat COVID-19.
The Korea Centers for Disease Control and Prevention said Friday that they will seek import approval from the nation's food and drug safety ministry as a government panel has concluded that remdesivir showed positive results and since there are no other anti-viral medication proven effective just yet.
Remdesivir was originally developed to treat Ebola, but has been found to cut hospital stay by 31-percent and reduce the fatality rate of COVID-19 infected patients by about five percentage points.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.